Männedorf, Switzerland — The Tecan Group (SIX Swiss Exchange: TECN) today issued a trading update for the second half of 2014. Tecan CEO David Martyr commented: “After a difficult first half with declining sales and our Partnering Business suffering from delays in order placement from two large customer accounts, it is good to see the […]
IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property based businesses, is pleased to note that portfolio company Genomics Ltd (“Genomics” or “the Company”), a spin-out from the University of Oxford that has developed an analytical platform for genomic sequence data analysis, has completed a £10.3 million fundraising. The […]
Bioo Scientific was awarded a National Science Foundation Phase II grant for $750,000 to continue development efforts to improve the accuracy of small RNA expression analysis. The value for developing a method to measure the true profile of microRNAs in a sample would be immense for the research community studying transcriptional regulation, and would open […]
SAN DIEGO, CA — BioNano Genomics, Inc., the leader in genome mapping, announced today the completion of a $53 million Series C financing. Legend Capital and Novartis Venture Fund co-led the round and were joined by Federated Kaufmann Fund and Monashee Investment Management as new investors. Existing investors Domain Associates, Battelle Ventures and Gund Investment […]
Sydney, Australia –- Genetic Signatures Ltd has launched its prospectus offering institutional and retail investors the opportunity to invest in the exciting growing global molecular diagnostics market prior to the Company’s listing on the Australian Stock Exchange on 23 December 2014. Molecular diagnostics (MDx) is a modern technique increasingly used by hospitals and pathology labs […]
Limerick, PA. -– Rockland Immunochemicals Inc. today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Health (NIH). Rockland will use the grant to develop synthetic antibodies for detection and quantitation of modified RNAs. Also known as aptamers, synthetic antibodies can be used in basic […]
OAKLAND — — Riffyn, Inc. has raised $1.8 million in a Seed financing round led by O’Reilly AlphaTech Ventures, with additional investments from Bioeconomy Capital and others. Riffyn provides experimental process design and analytics software to improve reproducibility and tech transfer in life science, chemical and materials research and development. The financing accelerates Riffyn’s efforts […]
WALTHAM, Mass.– Thermo Fisher Scientific Inc. (NYSE: TMO) announced today that it has priced its previously announced offering of €640 million aggregate principal amount of 2.000% senior notes due 2025 at an issue price of 99.680% of the principal amount. The issuance of the notes is expected to close on or about November 24, 2014, […]
WASHINGTON — Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will present at the Baird Industrial Conference in Chicago, Illinois today, Wednesday, November 12at 8:30 a.m. CT. The audio will be simultaneously webcast and the presentation will be archived on the Investors section of www.danaher.com under Investor Events. The […]
WILMINGTON, Mass. — Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has entered into an Indefinite Delivery / Indefinite Quantity (IDIQ) contract with the United States Transportation Security Administration (TSA) for its QS-B220 desktop explosives trace detectors, which recently received TSA qualification […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
